Valute / CRDF
CRDF: Cardiff Oncology Inc
2.10
USD
0.02
(0.96%)
Il tasso di cambio CRDF ha avuto una variazione del 0.96% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 2.06 e ad un massimo di 2.14.
Segui le dinamiche di Cardiff Oncology Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CRDF News
- AMD To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday - Arista Networks (NYSE:ANET), Advanced Micro Devices (NASDAQ:AMD)
- H.C. Wainwright lowers Cardiff Oncology stock price target on trial data
- Cardiff Oncology (CRDF) Q2 Loss Down 19%
- Why Is Cardiff Oncology Stock Trading Lower After Colorectal Cancer Data? - Cardiff Oncology (NASDAQ:CRDF)
- Avis Budget Group Posts Downbeat Earnings, Joins SoFi Technologies, Seagate And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Avis Budget Gr (NASDAQ:CAR), Cardiff Oncology (NASDAQ:CRDF)
- Why LendingClub Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), AtriCure (NASDAQ:ATRC)
- Cardiff Oncology shares plunge after Q2 earnings miss
- Cardiff Oncology (CRDF) Reports Q2 Loss, Lags Revenue Estimates
- Cardiff Oncology earnings missed by $0.02, revenue topped estimates
- Cardiff Oncology reports positive data from colorectal cancer trial
- Cardiff Oncology: Volatility Afoot With Onvansertib Update Near-Term (NASDAQ:CRDF)
- Cardiff Oncology stock initiated with Buy rating at Ladenburg Thalmann
- Cardiff Oncology: Trial Data Delay Unnerves Investors, But Bulls See Last Buy-Low Chance
- This Amylyx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Amylyx Pharmaceuticals (NASDAQ:AMLX), Amrize (NYSE:AMRZ)
- Cardiff Oncology stock initiated at Hold by Jefferies on early data concerns
- Cardiff Oncology appoints Roger Sidhu as new Chief Medical Officer
- 3 Best Stocks to Buy Now, 6/16/2025, According to Top Analysts - TipRanks.com
- Cardiff Oncology reports positive trial results for breast cancer treatment
- Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript
Intervallo Giornaliero
2.06
2.14
Intervallo Annuale
2.06
5.64
- Chiusura Precedente
- 2.08
- Apertura
- 2.12
- Bid
- 2.10
- Ask
- 2.40
- Minimo
- 2.06
- Massimo
- 2.14
- Volume
- 1.341 K
- Variazione giornaliera
- 0.96%
- Variazione Mensile
- -13.93%
- Variazione Semestrale
- -50.93%
- Variazione Annuale
- -8.30%
31 agosto, domenica